AzPA Pharmacy Flash

• US FDA Approves GSK's Benlysta Autoinjector for Lupus Nephritis
  The FDA has approved GSK's Benlysta autoinjector for individuals aged five and above with active lupus nephritis, providing a self-administered subcutaneous option and for pediatric patients.
• Precision BioSciences Gains FDA Rare Pediatric Disease Designation for PBGENE-DMD
  PBGENE-DMD, a drug for Duchenne muscular dystrophy, has been granted a Rare Pediatric Disease Designation by the FDA, under the Priority Review Voucher program.
• Pharmacists Expand Frontline Role in US Hospitals, Survey Finds
  U.S. hospitals are increasingly involving pharmacists in patient care, with over 75% assigning them to inpatient units and 72% deploying them in outpatient clinics for managing chronic diseases.